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Mycobacterium avium is an opportunistic pathogen associated with pulmonary disease in non-
AIDS patients and disseminated infection in patients with AIDS. The chief route of infection is by
colonization and invasion of the mucosa of the gastrointestinal tract, but infection through the
respiratory route also occurs. After crossing the mucosa, M. avium infects and replicates within
tissue macrophages. To identify M. avium genes required for survival in vivo, a library of signature-
tagged transposon mutants was constructed and screened for clones attenuated in mice. Thirty-
two clones were found to be attenuated for their virulence, from which eleven were sequenced
and tested further. All the mutants studied grew similarly in vitro to the wild-type MAC104. Ten
mutants were tested individually in mice, confirming the attenuated phenotype. MAV_2450, a
polyketide synthase homologue to Mycobacterium tuberculosis pks12, was identified. STM5 and
STM10 genes (encoding two hypothetical proteins MAV_4292 and MAV_4012) were associated
with susceptibility to oxidative products. Mutants MAV_2450, MAV_4292, MAV_0385 and
MAV_4264 live in macrophage vacuoles with acidic pH (below 6.9). Mutants MAV_4292,
MAV_0385 and MAV_4264 were susceptible to nitric oxide in vitro. The study of individual
mutants can potentially lead to new knowledge about M. avium pathogenic mechanisms.
INTRODUCTION
Mycobacterium avium is an opportunistic pathogenic
bacterium that infects many host cell types, although the
mononuclear phagocyte is the primary bacterial target. The
bacterium is taken up by macrophages and lives inside a
cytoplasmic vacuole, which does not acidify (Inderlied
et al., 1993; Sturgill-Koszycki et al., 1994). The M. avium
vacuole also does not follow the normal course of
maturation, such as excluding proteins like Rab7 (Via
et al., 1997), which has a role in the docking of the late
phagosome to lysosome. It is clear that M. avium, although
not as virulent as Mycobacterium tuberculosis, is capable of
surviving within host macrophages by subverting the
phagocytic cell functions (Bermudez et al., 2004; Crowle
et al., 1991). To do so, the bacterium has an array of
virulence factors, a few of them already described (Honer
Zu Bentrup et al., 1999; Krzywinska et al., 2005; Li et al.,
2005), but the majority are still unknown. It has also been
shown that the virulence of M. avium, both in macro-
phages as well as in mice, depends on the bacterium
morphotype. Smooth, rough, transparent or opaque,
represent the bacterial morphotypes encountered.
Although the smooth transparent morphotype is associated
with virulence in mouse, the opaque and even the rough
(without glycopeptidolipid) morphotypes have been iso-
lated from patients with AIDS (Falkinham, 1996; Inderlied
et al., 1993).
Several studies have identified M. avium genes expressed
within the macrophages. Hou and colleagues reported on
M. avium genes upregulated in macrophages using selective
capture of transcribed sequences (Hou et al., 2002). More
recently, Danelishvili et al. (2004) identified M. avium
genes expressed in macrophages by differential fluorescence
Abbreviations: IFN-c, gamma interferon; ROI, reactive oxygen
intermediate; SOD, superoxide dismutase; STM, signature-tagged
mutagenesis; WT, wild-type.
Tables of growth and susceptibility data for the wild-type and mutant
isolates are available as supplementary data with the online version of
this paper.
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other virulent genes were identified by screening of a
transposon library, such as the PPE-encoding gene
described by Li et al. (2005).
Despite the knowledge acquired regarding M. avium genes
associated with the pathogenesis of infection, very little is
known about their function. In addition, the genes
important for bacterial survival in vivo are mostly
unknown. In mice, following intravenous infection (via
the tail vein), a large portion of M. avium organisms are
located in the spleen and liver (Bermudez et al., 1999). Oral
infection is also associated with disseminated disease
(Bermudez et al., 1992). Bacteria cross the intestinal
mucosa through enterocytes, and many of them survive
in a latency-like state in mesenteric lymph nodes (Petrofsky
& Bermudez, 2005; Sangari et al., 2000). Dissemination to
the spleen, liver and bone marrow still often occurs
(Petrofsky & Bermudez, 2005). Once in the liver and
spleen, M. avium is found within macrophages and Kupffer
cells, respectively (L. E. Bermudez & M. Petrofsky,
unpublished results). The spread of the infection and
systemic dissemination requires escape from macrophages
and infection of, presumably, another macrophage
(Bermudez et al., 2004). A recent study demonstrated that
M. tuberculosis dissemination does seem to occur second-
ary to transport within phagocytic cells (Clay et al., 2007).
Once within macrophages, M. avium can resist reactive
oxygen intermediates (ROIs) and nitric oxide (NO)
(Appelberg & Orme, 1993; Bermudez & Young, 1989).
Differently from M. tuberculosis, the inactivation of
induced NO has no effect on M. avium survival in mice
(Cooper et al., 2000; Gomes et al., 1999). Therefore, thus
far no mechanism of killing of intracellular M. avium has
been identified, although it is known that macrophage
activation by tumour necrosis factor alpha and gamma
interferon (IFN-c) have important roles in M. avium killing
(Appelberg & Orme, 1993; Bermudez & Young, 1989).
Signature-tagged mutagenesis (STM) has been used by a
number of groups to identify bacterial genes required for
the survival and replication in the host (Camacho et al.,
1999; Cox et al., 1999; Hensel et al., 1995). It allows for
large pools of bacterial clones to be screened simulta-
neously. Therefore, to get new insight on M. avium
pathogenesis, we created and screened STM mutants in
mice. We identified several genes that, when inactivated,
resulted in attenuation of M. avium in vivo, and initial
studies have suggested potential mechanisms of action.
METHODS
Bacterial strains and growth conditions. Escherichia coli XL1-blue
was used for the cloning experiments. It was grown at 37 uCo n
Luria–Bertani broth supplemented with 50 mg kanamycin ml
21. The
M. avium strain 104, isolated from the blood of an AIDS patient and
shown to be virulent in mice, as well as the mutants, were grown on
Middlebrook 7H9 broth or 7H11 agar (Difco) supplemented with
0.2% glycerol, 0.05% Tween 80 and oleic acid, albumin glucose and
catalase, as reported previously (Bermudez et al., 1992, 2004).
Construction of plasmid pYJTags. The transposon Tn5367 derived
from IS1096 was extracted from pYUB285 on a HindIII and EcoRI
fragment, and cloned into the HindIII and EcoRI restriction sites of
the E. coli vector pUC19 to create pYJL1. The mycobacteria
temperature-sensitive origin of replication was amplified from
pYUB285 by using primers with HindIII restriction site, and was
cloned into pYJL1. The resulting plasmid was named pYJL2. Double-
stranded DNA tags were produced by PCR amplification using a
variable oligonucleotide pool RTCG as template DNA that was 59-
AAACTAACTAGTTACAACCTCAAGCTT-(NK)20-AAGCTTGGTT-
AGATGACTAGTATTAAA-39. The primers used to amplify the tags
were pTag1 (59-AAACTAACGCGTTACAACCTC-39), pTag2 (59-
TTTAATACGCGTCATTCTAACC-39), pTag3 (59-TAGTTACAACC-
TCAAGCTT-39) and pTag4 (59-TAGTCATTCTAACCAAGCTT-39).
For the cloning, the tags were amplified using the RTCG template, and
pTag1 and pTag2 as primers. The PCR was performed using an
AmpliTaq kit (Perkins-Elmer) with a 50 ml reaction containing 200 pg
RTCG, pTag1 and pTag2 (100 pg), 1.5 M MgCl2 and 250 mM each of
dATP, dGTP, dCTP dTTP, 16Taq buffer and 5 U AmpliTaq. The
cycle conditions used were the same as described by Hensel et al.
(1995). PCR products were purified using a PCR purification kit
(Qiagen), digested with MluI, dephosphorylated and ligated into the
vector pYJL2. The ligation mixture was used to transform E. coli, and
the transformants were selected on Luria–Bertani agar plate containing
50 mg kanamycin ml
21. The plasmids were analysed by restriction
enzyme digestion to verify that tags had been incorporated into pYJL2.
The resulting plasmid with a mixture of tags was named pYJTags.
Construction of the M. avium mutant library. A pool of 5000 E.
coli transformants was used to prepare plasmid pYJTags DNA (Fig. 1).
These plasmids were electroporated into M. avium 104 strain, as
described previously (Dam et al., 2006; Li et al., 2005), and
transformants were selected on 7H11 medium containing 200 mg
kanamycin ml
21. A total of 50 transformants containing pYJTags
were obtained and used to produce 50 different mutant banks. A
library of 2064 mutants picked randomly from 50 banks was
organized and grown in microtitre plates containing 7H9 medium
supplemented with 400 mg kanamycin ml
21 at 30 uC. After shifting
the temperature to 41 uC for 3 days, the suspension was plated onto
7H11 agar plates with 400 mg kanamycin ml
21. Hundreds of mutants
were obtained from each well. One colony was picked up from each of
50 individual plates to form 48 pools of 50 clones, each containing 50
different tags. A series of membranes containing the 50 different tags
was produced by amplifying the different tags using pTag3 and pTag4
primers, and transferring them onto nylon N
+ membrane using a
manifold apparatus.
Labelling of input and output probe, and hybridization. For
amplification of the output probes from the spleens of the infected
mice, homogenized spleen was plated onto solid medium supple-
mented with 400 mg kanamycin ml
21. After 7 to 10 days, mutant
pools were recovered from the plates as output probes. For amplifying
tags from the input of M. avium mutants, the pool containing 50
different tags was grown in 7H9 broth with 400 mg kanamycin ml
21,
and bacterial cells were lysed using a high temperature incubation
protocol (100 uC for 10 min and 4 uC for 1 min, 4 cycles). A 20 ml
aliquot of supernatant was used for the 50 ml PCR; the PCR product
was purified with a PCR purification kit (Qiagen), and labelled with
non-radioactive digoxin with a DIG-Chem-Link labelling and
detection set (Roche). The probe was digested with HindIII and
purified to remove the non-specific arms consisting of the tags.
Prehybridization, hybridization and washes were carried out at 68 uC
using the DIG Wash and Block Buffer set hybridization kit from
Roche. CDP-Star chemiluminescent substrate for alkaline phospha-
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1 to 10 min at room temperature, depending on the signal strength.
Mapping of transposon insertion and sequence analysis. To
identify the transposon insertion site, chromosomal DNA from the
mutant isolates was prepared. The interrupted unknown sequence
was amplified using non-specific PCR as described previously
(Danelishvili et al., 2004). The product was purified and directly
sequenced using an ABI 373 DNA sequencer with a Taq dideoxy
terminator cycle sequencing kit (Perkin-Elmer Cetus). Only
sequences containing the transposon were considered. The sequences
were mapped on the M. avium genome sequence [The Institute for
Genomic Research (TIGR) database] and M. tuberculosis H37Rv
genome sequence using the BLAST program.
Complementation of genes. To address the importance of the
genes inactivated on M. avium virulence, complementation of the
genes MAV_2450, MAV_4292, MAV_1346, MAV_4012 and
MAC_4264 was carried out using a recently published strategy (Li
et al., 2005). Specific primers were designed and used to amplify the
four genes from genomic DNA using PCR as described previously (Li
et al., 2005). The amplification product was then cloned in pMV261-
Apr plasmid and used to transform the mutants STM1 (STM1 comp),
STM5 (STM5 comp), STM8 (STM8 comp), STM10 (STM10 comp)
and STM11 (STM11 comp). Clones containing the plasmid were
selected in presence of 200 mg apramycin ml
21. Selected clones were
confirmed for the presence of the plasmid.
Mice infection studies. In order to screen clones for attenuated
mutants, 0.2 ml (1610
8 c.f.u.) each input pool were injected
intravenously into C57BL/6 mice (Jackson Laboratories). Mice were
observed, and 3 weeks post-infection mice were sacrificed by cervical
dislocation, spleens removed aseptically and homogenized. Series
dilutions of spleen homogenates were plated onto 7H11 with
kanamycin at 400 mgm l
21. The colonies were collected and
processed, as described above, to make the output probe tags.
To prove that the strains identified in the initial screen were, in fact,
attenuated mutants, mice were injected intravenously with 3610
7
individual bacterial mutant. Twelve mice were used for each of the
time points. In two independent experiments (with a total of 48
animals per time point), organs were removed 1 day, 1 week, 3 weeks
and 5 weeks post-infection, homogenized, and serially diluted and
plated onto 7H11 plates, as previously reported (Bermudez et al.,
1992, 1997). The number of c.f.u. was determined and compared with
the number of colonies in the spleen of mice infected with the wild-
type (WT) bacterium.
Macrophages and specimen preparation. Human monocyte-
derived macrophages were isolated and prepared as previously
described (Bermudez et al., 1997, 2004). Cells were adjusted to 10
5
cells ml
21 and seeded for 18 to 24 h on sterile, Formvar-coated
London finder-gold grids (Electron Microscopy Sciences) in RPMI
1640 supplemented with 10% fetal bovine serum (Sigma Chemicals).
The monolayers were infected with M. avium strains for 1 h with an
approximate ratio of 10 bacteria per macrophage, as reported
previously (Bermudez et al., 1997, 2004). After infection, specimens
were fixed in 1% paraformaldehyde, pH 7.2, for 30 min. The grids
were then washed and chambers were observed for identification of
bacteria or phagosomes, as previously reported (Wagner et al., 2005).
In other studies, RAW 246.7 macrophage monolayers (5610
5 cells),
cultured in presence of Dulbecco’s modified Eagle’s medium
supplemented with 10% heat inactivated fetal bovine serum, were
stimulated with 100 mg recombinant mouse IFN-c ml
21 and
subsequently infected with different M. avium strains for 1 h (m.o.i.
of 10), and washed to remove extracellular bacteria (Bermudez et al.,
1992; Li et al., 2005). Depending on the experiment, 2 mg bovine
superoxide dismutase (SOD) ml
21 (Sigma Chemicals) or N-
methylarginine (Sigma) at 100 mM concentration was added con-
comitantly with the bacteria. These concentrations of inhibitors are
known to suppress O2 and NO, respectively, in infected macrophages
(Bermudez, 1993). Prior studies have shown that neither SOD nor N-
methyl-arginine has any effect on monocyte and macrophage
phagocytosis (data not shown). Monolayers were kept for 24 h and
then lysed as previously described (Bermudez et al., 1992; Li et al.,
2005). The macrophage lysate was serially diluted and plated onto
7H10 agar plates. Plates were incubated at 37 uC for 10 days and the
number of colonies quantified (Bermudez et al., 1992; Li et al., 2005).
In some experiments, intracellular bacteria were allowed to grow
inside macrophages for 4 days before lysing. Macrophage viability was
monitored during the experiments to evidence differential detach-
ment of macrophages from monolayers (Bermudez et al., 1992; Li
et al., 2005).
Vacuole pH. Measure of the vacuole pH was performed as previously
described (Li et al., 2005). Briefly, to label bacteria, mid-exponential
growth phase M. avium, WT and mutants, were washed in PBS and
resuspended in PBS with 0.05% Tween 80. Bacteria were labelled with
fluorescent probes NHS-CF and NHS-Rho (10 mg each).
Measurements were made in a fluorimeter (CytoFluor II;
Fig. 1. Schematic representation of the approach used. The
pYJTags was created from pUC19 with the insertion of a
temperature-sensitive (ts) Myc ori. It allowed for the integration
of the transposon once the environmental temperature was
elevated to 41 6C.
Y. Li and others
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505 nm and emission at 505–555 nm. Calculation of phagosome pH
for each well was carried out according to the standard calibration
curve based on CF/Rho ratio versus pH, according to the method
previously reported (Li et al., 2005).
Susceptibility to NO. The NO donor NOR-3 was used to determine
the effects of reactive nitrogen substances on M. avium strains. NOR-3
was dissolved in 15 mM Tris/HCl, pH 7.4, and was quantified
spectrophotometrically. The NOR-3 (NO donor) was added to the
culture of M. avium, WT or mutants, for 60 min. Afterwards, bacteria
werequantifiedbyplatingthedilutedsuspensionto7H10agarmedium.
Statistical analysis. Results of experimental studies in mice were
analysed by Student’s t-test. Each number represented the total
number of mice divided into two different experiments. Experiments
in vitro were analysed using ANOVA. The P values ,0.05 were
considered significant.
RESULTS AND DISCUSSION
M. avium is an intracellular opportunistic pathogen that
infects and survives within host macrophages. M. avium is
acquired from the environment, and its ability to cross the
mucosal barrier and infect submucosal macrophages
appears to be key for the establishment of infection
(Bermudez et al., 1997; Inderlied et al., 1993; Sangari et al.,
2000). Several studies have identified virulence determinants
in vitro that allow the bacterium to enter (Dam et al., 2006;
Miltneretal.,2005)andsurvivewithinmacrophages(Honer
Zu Bentrup et al., 1999; Hou et al., 2002; Krzywinska et al.,
2005; Li et al., 2005). Although some other studies have
determined the expression of M. avium genes in mono-
nuclear phagosomes in vitro (Danelishvili et al., 2004; Hou
et al., 2002) and in vivo (Li et al., 2005), very little has been
performed in an attempt to identify virulence genes
important forthe survival in thehost using an in vivo model.
Identification of attenuated mutants
To identify M. avium mutants attenuated in vivo,w e
partially screened an STM library in mice (2064 clones).
Thirty-two clones with significant attenuation in vivo,i n
comparison to the WT bacterium, were identified by
comparing the hybridization of the pool of DNA from
bacteria in the spleen after 3 or 5 weeks of infection with
the pool of DNA of the bacterial inoculum before
administration (Fig. 1). Eleven clones were sequenced
and further tested individually. The clones STM1 and
STM7 had the transposon inserted in the same gene. The
inactivated genes were sequences as described in Methods
and elsewhere (Danelishvili et al., 2004; Li et al., 2005). The
genes inactivated in the sequenced mutants are listed in
Table 1. To confirm the phenotype of the isolated mutants,
we infected C57BL/6 mice intravenously with the indi-
vidual mutants (except for STM7 and STM9), and the
number of bacteria in the spleen (compared with the WT
MAC 104) was determined at 24 h, 1 week, 3 weeks and 5
weeks. STM7, as for STM1, had the pks12 gene inactivated,
and STM9 had a transposon in a chaperonin and was
considered less relevant than other mutants. As shown in
Table 2, some mutants were attenuated at the first week of
infection (STM5, STM6 and STM10), some were attenu-
ated after 3 weeks of infection (STM1, STM3, STM4, STM8
and STM11) and only one clone showed attenuation in
mice only after 5 weeks of infection (STM2).
In vitro growth
To determine whether or not the identified mutants had
impaired growth ability in vitro, growth curves were
established in 7H9 broth. STM1, STM7, STM5–6 and
STM8–11 were grown in parallel to M. avium 104, and the
growth curve determined over 10 days. Growth of all
mutant strains was similar to the WT bacterium.
In the current study, we identified a number of M. avium
clones that were attenuated in vivo by using an STM
system. The attenuation of the individual mutants was then
confirmed by challenge experiments, and some of the genes
were complemented, leading to the recovery of the virulent
phenotype. Some of the genes associated with attenuation
in vivo were those encoding the polyketide synthases 11
Table 1. Genes inactivated in the identified mutants
Attenuated mutants were identified by screening an STM library. The mutants were tested individually for attenuation.
Clone M. avium gene Function
STM1/STM7 MAV_2450 Polyketide synthase 12
STM2 MAV_3321 ABC transporter, ATP-binding subunit
STM3 MAV_3105 Polyketide synthase 11
STM4 MAV_2723 PAP A2 condensation domain
STM5 MAV_4292 Hypothetical protein
STM6 MAV_0385 N-Acetylmuramyl-L-alanine amidase
STM8 MAV_1346 PE family protein
STM9 MAV_4366 Chaperonin GroES
STM10 MAV_4012 Conserved hypothetical protein
STM11 MAV_4264 Hypothetical protein, homology with bacterial regulatory protein TetR domain
M. avium virulence gene identification using STM
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synthesis and transport of polyketides are required for M.
tuberculosis growth and virulence in mice (Appelberg &
Orme, 1993; Hahn et al., 2005; Jain & Cox, 2005; Wagner et
al., 2005). In addition, the work by Hou et al. (2002)
demonstrated that the polyketide synthase 11 encoding
gene was upregulated upon uptake of M. avium by
macrophages. Polyketides are involved in cell-wall-lipid
synthesis and the integrity of the outer surface of
mycobacteria. They participate in the synthesis of dimy-
cocerosyl phthiocerol, which has been suggested as playing
a role in the permeability of the cell wall (Camacho et al.,
2001). In M. tuberculosis, 24 polyketide synthases have been
annotated (Cole et al., 1998); while in M. avium, there are
at least 22 polyketide synthases, all with significant
homology to the ones in M. tuberculosis (L. E. Bermudez
& Y. Li, unpublished observation). Polyketides were also
associated with modulation of the host immune response
to infection by impacting on cytokine production by
infected macrophages (Converse et al., 2003). Polyketides
are transported to the surface of M. tuberculosis by a unique
transport mechanism involving several genes of the mmpL
family (Camacho et al., 1999; Converse et al., 2003;
Domenech et al., 2004). In M. avium, the role of mmpL
genes has not yet been defined, but infections of
macrophages have been associated with the expression of
the MmpL transport proteins (Danelishvili et al., 2004;
Hou et al., 2002), and it is likely to be somewhat similar to
the role in M. tuberculosis.
The identification of an ABC transporter subunit as
virulence factor points to the importance of secreted
proteins. ABC transporters are two-protein complexes, one
protein involved in transport and the other providing
energy for the process. One recent ABC transporter linked
with virulence in mycobacteria is involved in the transport
of oxidoreductase associated with the invasion of epithelial
cells (Patel et al., 2006). Other ABC transporters have been
identified in screening for mycobacterial virulence genes
using several methods, but the functions have not been
characterized.
Our screen also identified a PE protein (mycobacterial
protein rich in proline and glutamic acid), GroES, a
polyketide synthase-associated protein and many proteins
of unknown function, some of them not present in M.
tuberculosis but with homology to Mycobacterium para-
tuberculosis. PE, PPE and PE-PGRS are families of proteins
that have been linked with virulence of Mycobacterium
marinum and M. tuberculosis (Dubnau et al., 2002;
Ramakrishnan et al., 2000). Some PE proteins have more
recently been described as exported proteins, with
expression on the surface of the bacterium (Delogu &
Brennan, 2001) and are expressed differently in host tissues
(Delogu et al., 2006). In fact, PE–PGRS proteins apparently
have different patterns of expression, as evidenced by
studies with M. tuberculosis, M. marinum and M. avium
(Dheenadhayalan et al., 2006b; Li et al., 2005;
Ramakrishnan et al., 2000). Initially, PE, PPE and PE–
PGRS groups of proteins were suggested as being involved
in the interaction with the host immune system, and being
important antigenic determinants of M. tuberculosis (Cole
et al., 1998). Although these families of proteins may be
important to the immune response of the host, it is
increasingly evident that several of them are involved in the
pathogenesis of the infection, as shown by the requirement
for survival in granulomas (Ramakrishnan et al., 2000) and
within macrophages (Li et al., 2005). Our current work
identified another PE protein in M. avium important for
full virulence in vivo. Its function is unknown at this point,
but recent work demonstrates that PE–PGRS 33 of M.
tuberculosis, when expressed in Mycobacterium smegmatis,
Table 2. Comparison of the number of organisms in the WT strain MAC 104 and the other STM clones at
several time points following infection of mice
C57BL/6 mice were infected intravenously and their spleens were harvested at 24 h, and at weeks 1, 3 and 5, for quantification
of the bacterial load.
Clone No. of c.f.u. per organ
24 h 1 week 3 weeks 5 weeks
STM1 6.7±0.3610
6 6.7±0.4610
6 6.1±0.4610
5* 5.2±0.3610
4*
STM2 6.1±0.3610
6 6.5±0.4610
6 6.0±0.2610
6 4.9±0.2610
3*
STM3 5.5±0.5610
6 2.3±0.2610
6 1.2±0.1610
6* 8.6±0.4610
5*
STM4 5.6±0.4610
6 3.2±0.3610
6 2.0±0.2610
6* 1.4±0.3610
6*
STM5 3.8±0.2610
6 1.1±0.2610
6* 1.5±0.1610
6 9.4±0.7610
5*
STM6 2.3±0.9610
6 1.1±0.7610
6* 8.3±0.6610
5* 8.1±0.5610
5*
STM8 1.6±0.2610
6 1.8±0.6610
6* 1.8±0.4610
6 1.9±0.3610
5*
STM10 3.2±0.4610
6 1.1±0.3610
6* 2.0±0.4610
6 7.3±0.3610
4*
STM11 5.1±0.3610
6 2.7±0.4610
6 8.5±0.3610
5* 5.3±0.6610
4*
WT (MAC 104) 1.9±0.2610
6 3.8±0.2610
6 1.3±0.2610
7 4.6±0.4610
7
*P,0.05 compared with the WT MAC 104 at the same time point.
Y. Li and others
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2006a). Chaperonins, such as GroEL, have recently been
associated with mycobacterial virulence (Ojha et al., 2005).
GroEL1 has been linked with the ability of M. smegmatis to
form biofilms (Ojha et al., 2005) by modulating the
synthesis of mycolates. The role in cell-wall synthesis may
impact on the ability of the bacterium to interact with the
host. In the case of GroES, the association with virulence has
not been established yet, but the fact that the inactivation of
the genes is associated with attenuation early in the infection
in vivo, indicates that GroES might have other, still
unknown, function(s). The different functions of stress-
related proteins are still not completely known.
Inactivation of the genes encoding the polyketide synthases
11 and 12 was associated with lack of growth from the
beginning of the infection, but major attenuation was only
observed after 3 weeks following challenge. Those results
agree with what has been described for clones with the
inactivation of pks12 in M. tuberculosis (Sirakova et al.,
2003). In contrast, the inactivation of the PE-encoding
gene was associated with significant bacterial attenuation 5
weeks after infection, indicating that this protein may have
function important for survival during the host adaptive
response leading to the activation of macrophages or with
the spreading phase of the infection, as recently suggested
(Dheenadhayalan et al., 2006a). Polyketide synthases 11
and 12, as proteins associated with surface moieties, could
potentially impact on the ability of the bacterium to
interact with the environment.
Attenuation in macrophages
To examine whether the STM mutants were attenuated in
macrophages, RAW 246.7 mouse macrophages were
infected and the growth was followed for 4 days. It was
observed that all mutants but STM3 and STM4 had no
significant attenuation in macrophages in vitro. It suggests
that the attenuation of STM3 and STM4 in vivo is probably
not related with the innate immune response
(Supplementary Table S1 available with the online
journal). It was also determined that attenuation was due
to increased susceptibility to superoxide anion or nitric
oxide. STM5 and STM10 showed increased sensitivity to
ROIs (Table 3), while STM10 and STM11 were susceptible
to nitric oxide (Table 4). The concentrations of inhibitors
used in these assays are knows to suppress O2 and NO in
infected macrophages.
Susceptibility to NO
To examine whether STM strains are susceptible to NO in
vitro, we incubated the strains STM1, 5, 10 and 11 in the
presence of NO donor and verified the viability afterward.
As shown in Supplementary Table S2 (available with the
online journal), the mutants STM5 and STM10 were
susceptible to NO at a concentration of 1 mM.
We identified a number of mutations in M. avium genes of
unknown function that are associated with attenuation in
vivo. Some of the genes inactivated, such as those
homologous to MAV_4292 and MAV_4012, lead to
increased susceptibility to SOD and NO (MAV_4012 and
MAV_4264), raising interesting questions about the
mechanisms of bacterial resistance to these toxic products
of phagocytic cells. Production of superoxide anion is
ineffective as a mechanism of killing of the majority of the
M. avium strains (Bermudez & Young, 1989; Gunzel et al.,
2006; Sarmento & Appelberg, 1996). Likewise, the role of
NO, in contrast to M. tuberculosis, has not been established
Table 3. Susceptibility of M. avium attenuated clones to superoxide anion
M. avium strain No. of c.f.u. (ml macrophage lysate)
”1*
1 h 24 h
”SOD +SOD
WT (MAC 104) 2.1±0.3610
5 3.3±0.5610
5 2.1±0.4610
5
STM1 3.6±0.4610
5 1.1±0.3610
5 1.5±0.2610
5
STM2 2.7±0.3610
5 9.0±0.2610
4 8.6±0.3610
4
STM3 5.1±0.5610
5 3.0±0.2610
5 2.6±0.4610
5
STM4 2.3±0.4610
5 2.0±0.5610
5 1.8±0.3610
5
STM5 3.0±0.5610
5 8.2±0.4610
4 2.0±0.5610
5D
STM6 3.9±0.2610
5 1.9±0.3610
5 1.6±0.4610
5
STM8 3.6±0.5610
5 8.1±0.2610
4 7.6±0.4610
4
STM10 3.7±0.3610
5 8.5±0.4610
4 1.0±0.3610
5D
STM11 4.7±0.3610
5 8.1±0.6610
4 8.5±0.2610
4
*RAW 246.7 macrophage monolayers were infected with M. avium for 1 h and extracellular bacteria were
removed by washing. Some wells were incubated with 2 mg SOD ml
21, as reported in Methods. Monolayers
were lysed at 24 h and viable intracellular bacteria quantified. The experiment was repeated three times.
DP,0.05 compared with the number of c.f.u. (ml macrophage lysate)
21 at 24 h without adding SOD.
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the inability of macrophages to produce nitric oxide leads
to increased control of the infection (Appelberg & Orme,
1993; Bermudez, 1993; Gomes et al., 1999). MAV4012 is a
transcription regulator, and its inactivation was associated
with increased susceptibility to ROIs and NO. Because
MAV_4012 is a transcription regulator, one might suggest
that the expression of this gene regulates the expression of a
number of membrane-associated genes. When tested
individually for susceptibility against NO, STM10,
STM11 and, to a lesser extent, STM5 were susceptible.
The reason for the discrepancy between the results
obtained in macrophages and regarding STM5 susceptibil-
ity in vitro to NO is unknown at this point. MAV_4292 is a
gene encoding a protein of unknown function. Of
importance is the finding that other proteins, but not
SOD or correlated protein, were identified associated with
resistance to superoxide anion and reactive nitrogen
intermediates. Future studies will address these specific
questions.
Vacuole pH
We determined the pH of the vacuole of STM mutants and
compared it to the WT pH. As shown in Table 5, while the
M. avium 104 vacuole pH was 6.4 at 15 min and 6.9 at
24 h, STM1, STM5, STM10 and STM11 had significant
acidification in the macrophage vacuole. The vacuole of
STM6, although significantly more acidic than the WT
bacterium, was less acidic than the vacuole of the other
STM mutants.
The pH in the vacuole of the STM mutants was acidic, in
contrast to the pH of the vacuole of the WT bacterium.
Except for one strain, in which the gene inactivated is a
regulator, all other mutants had significantly less decrease
in the pH of the vacuole compared with M. avium 104. The
interpretation of the findings suggests that MAV_4264
regulates a series of genes that participate in the bacterial
inhibition of phagosome acidification.
Complementation of phenotype
Complementation of STM1, STM5, STM8, STM10 and
STM11 mutants was accomplished and the complemented
clones were then evaluated for attenuation in RAW 246.7
macrophages. The results, shown in Table 6, indicate that
the complementation of STM1, STM5, STM8 and STM10
recovered the virulent phenotype, with similar results to
WT, while the attempt to complement STM11 was only
partially successful (Table 6).
Table 4. Susceptibility of M. avium clones to the effect of nitric oxide
M. avium strain No. of c.f.u. (ml macrophage lysate)
”1*
1 h 24 h
”N-MA +N-MA
WT (MAC 104) 6.4±0.3610
5 8.3±0.3610
5 8.7±0.5610
5
STM1 2.0±0.4610
5 8.1±0.3610
4 8.5±0.6610
4
STM2 4.4±0.2610
5 7.6±0.3610
4 8.1±0.2610
4
STM3 5.2±0.5610
5 4.1±0.3610
5 3.8±0.4610
5
STM4 2.6±0.2610
5 1.0±0.3610
5 9.8±0.2610
5
STM5 3.4±0.2610
5 9.8±0.3610
4 1.0±0.4610
5
STM6 3.9±0.5610
5 2.8±0.4610
5 2.7±0.6610
5
STM8 3.8±0.2610
5 8.3±0.3610
4 7.6±0.5610
4
STM10 4.6±0.3610
5 4.1±0.5610
4 1.6±0.3610
5D
STM11 2.5±0.5610
5 7.8±0.4610
4 1.2±0.6610
5D
*RAW 246.7 macrophage monolayers were infected for 1 h with M. avium, washed, and all of the wells were
treated with IFN-c and with 100 mM N-methylarginine. The monolayers were lysed after 24 h and the
intracellular bacteria quantified. The experiments were repeated three times.
DP,0.05 compared with the number of bacteria at 24 h without N-methylarginine.
Table 5. Vacuole pH of RAW 264.7 macrophages
Strain pH
15 min 24 h
WT (MAC 104) 6.4 6.9
STM1 5.3* 5.6*
STM5 5.5* 5.7*
STM6 5.7* 6.5*
STM10 5.2* 5.1*
STM11 4.8* 4.5*
*P,0.05 compared with the WT MAC 104. Experiments were
repeated three times.
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In summary, by screening an STM library, we have
identified a number of virulence genes in M. avium
required for the survival of the bacteria in macrophages
and in the experimental host. Several of the genes appear to
be directly associated with the resistance to macrophage
mechanisms of killing.
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